European Urology Oncology
Scope & Guideline
Exploring the frontiers of urology and oncology for tomorrow's healthcare.
Introduction
Aims and Scopes
- Prostate Cancer Research:
The journal covers extensive research on prostate cancer, including advanced treatment options, diagnostic techniques, and the role of biomarkers in predicting outcomes. - Bladder Cancer Studies:
Significant attention is given to bladder cancer, focusing on surgical techniques, immunotherapy, and the efficacy of various treatment regimens. - Renal Cell Carcinoma Insights:
Research on renal cell carcinoma encompasses clinical trials, treatment strategies, and the molecular characteristics of the disease. - Emerging Diagnostic Technologies:
The journal highlights advancements in imaging techniques such as MRI and PET scans, which are crucial for accurate diagnosis and treatment planning. - Health Economics and Quality of Life:
There is a focus on assessing the cost-effectiveness of treatments and understanding the impact of cancer therapies on patients' quality of life. - Multidisciplinary Approaches:
The journal promotes collaborative research efforts, integrating insights from urologists, oncologists, radiologists, and pathologists to enhance treatment outcomes.
Trending and Emerging
- Immunotherapy and Targeted Therapies:
There is a growing focus on immunotherapeutic approaches and targeted therapies, particularly in the treatment of advanced prostate and bladder cancers, indicating a shift towards more personalized medicine. - Liquid Biopsy and Biomarkers:
Emerging trends highlight the use of liquid biopsies and genomic biomarkers for early detection and monitoring of treatment response, showcasing advancements in non-invasive diagnostic technologies. - Artificial Intelligence in Oncology:
The integration of artificial intelligence and machine learning in diagnostics and treatment planning is gaining traction, with studies exploring their applications in improving patient outcomes. - Health Disparities and Access to Care:
An increasing number of articles address health disparities in cancer care, focusing on access to treatments and the socioeconomic factors affecting patient outcomes. - Quality of Life Assessments:
Research emphasizing the importance of patient-reported outcomes and quality of life in treatment decision-making is on the rise, reflecting a holistic approach to cancer care.
Declining or Waning
- Traditional Surgical Techniques:
There has been a noticeable decrease in publications focusing solely on traditional surgical approaches, as the field increasingly emphasizes minimally invasive and robotic-assisted techniques. - Basic Science Research:
The journal has seen a waning interest in purely basic science studies, particularly those not directly linked to clinical applications or translational research. - Single-modality Treatments:
Research focusing exclusively on single-modality treatments (e.g., surgery or radiation alone) is appearing less frequently, as the trend shifts towards multimodal and personalized treatment approaches.
Similar Journals
African Journal of Urology
Advancing Urological Excellence Across AfricaAfrican Journal of Urology (ISSN: 1110-5704, E-ISSN: 1961-9987) is a leading scholarly publication in the field of urology, published by SPRINGER from the United Kingdom. Since adopting an open access model in 2012, this journal has aimed to increase the visibility and dissemination of vital research findings across the African continent and beyond. With a current impact factor and significant standing, as denoted by its Q3 ranking in Urology for 2023, it serves as an essential platform for clinicians, researchers, and students alike. The journal's scope encapsulates all aspects of urology, fostering advancements in both clinical practices and innovative research while specifically addressing healthcare challenges relevant to African populations. As part of its commitment to accessibility and academic excellence, the journal offers full open access to its content, allowing for a broad readership and engagement with cutting-edge studies. Engage with the African Journal of Urology to contribute to and stay informed about vital developments in urological science.
ORAL ONCOLOGY
Fostering Innovation in Oral Cancer StudiesORAL ONCOLOGY is a leading peer-reviewed journal published by Elsevier, dedicated to advancing the field of oncology with a specific focus on oral diseases and cancers. Since its inception in 1996, this esteemed journal has provided a platform for high-quality research that addresses critical issues in oral surgery, cancer research, and related disciplines. With impressive rankings in Q1 in Oncology and Q1 in Oral Surgery, and recognized as Rank #1 in Dentistry and Oral Surgery by Scopus, ORAL ONCOLOGY consistently publishes impactful articles that contribute significantly to our understanding of oral cancers. The journal is committed to sharing pioneering findings that enhance clinical practices and improve patient outcomes. As a non-open access journal, it provides readers with exclusive access to cutting-edge research, ensuring that professionals, researchers, and students are at the forefront of developments in the field. Situated in the United Kingdom, ORAL ONCOLOGY serves as an indispensable resource for those dedicated to advancing oral health and oncology research through rigorous scientific inquiry and collaboration.
American Journal of Clinical and Experimental Urology
Transforming research into practice for better urological health.American Journal of Clinical and Experimental Urology is a pivotal platform for the dissemination of cutting-edge research in the field of urology. Published by E-CENTURY PUBLISHING CORP, this peer-reviewed journal aims to enhance the understanding and application of clinical and experimental practices in urological science. The journal prioritizes high-quality, original research articles, reviews, and case studies that provide valuable insights for urologists, researchers, and healthcare professionals alike. With an increasing focus on evidence-based approaches to urological health, AJCEU serves as an essential resource for those who strive to advance diagnostic and therapeutic methodologies. Though currently not indexed in major databases, the journal is committed to expanding its reach within the academic community, thus fostering collaboration and innovation in urology. The open access model allows for broader distribution and engagement with the latest findings in the field, making it an indispensable tool for scholars and practitioners dedicated to advancing urological care and research.
EUROPEAN UROLOGY
Pioneering research in the heart of urology.EUROPEAN UROLOGY is a prestigious journal in the field of urology, published by Elsevier, and residing in the vibrant academic landscape of the Netherlands. Since its inception in 1975, the journal has made significant contributions to urological research, earning a top rank of #1 out of 120 in the Scopus category of Medicine - Urology, placing it within the esteemed 99th percentile of its field. With a commitment to disseminating cutting-edge research, clinical findings, and innovative practices, EUROPEAN UROLOGY has established itself as a pivotal resource for urologists and researchers alike. Although it does not offer open access options, it provides an indispensable platform for scholarly communication that drives advancements in patient care and medical knowledge. As the journal embarks on converged years leading up to 2024, it continues to strive for excellence in urology, welcoming contributions that reflect the latest scientific advancements and clinical applications.
Central European Journal of Urology
Empowering Professionals with Cutting-Edge InsightsThe Central European Journal of Urology, published by the Polish Urological Association, serves as a vital platform for the dissemination of cutting-edge research in the field of urology. Established in 2009 and continuing through 2024, this journal aims to foster innovation and collaboration among researchers, clinicians, and students by offering a forum for high-quality, peer-reviewed articles that highlight advancements in urological science and practice. Currently holding a Scopus rank of #68 out of 120 in the Medicine_Urology category, and a 2023 quartile ranking of Q3, it is positioned to provide valuable insights into emerging trends and techniques. Although being a subscription-based journal, it remains crucial for professionals seeking to stay updated on the latest developments in urology, contributing significantly to the global conversation in this specialty. With its strong ties to the academic community and dedication to excellence, the Central European Journal of Urology continues to be an indispensable resource for those advancing knowledge and practice in urology.
UROLOGY
Bridging Research and Practice in UrologyUROLOGY is a prestigious journal published by Elsevier Science Inc, renowned for disseminating high-quality research and reviews in the field of urology. With an ISSN of 0090-4295 and E-ISSN 1527-9995, this journal has been a trusted resource since its inception in 1973 and continues to provide insights into the latest advancements and clinical practices in urology, maintaining a category quartile of Q2 as of 2023. The journal ranks 50th out of 120 in the Scopus metrics for Medicine - Urology, placing it in the 58th percentile, which underscores its influence and relevance in the academic community. Although it is not structured as an open access journal, it offers a wealth of knowledge vital for researchers, healthcare professionals, and students alike, enabling them to stay abreast of evolving treatments and innovations in the field. As we move towards 2024, UROLOGY remains committed to advancing research and enhancing practices in urological care, fostering a collaborative environment among its readership.
Prostate Cancer
Transforming research into real-world impact for prostate cancer.Prostate Cancer is a leading peer-reviewed Open Access journal published by HINDAWI LTD, dedicated to advancing the field of urology and oncology through high-quality research and innovative studies. Established in 2011, this journal serves as a vital platform for disseminating findings related to prostate cancer diagnostics, treatment strategies, and patient care, striving to collaborate and connect researchers from around the globe. With an impact factor reflective of its critical input in the scientific community, the journal showcases compelling manuscripts, reviews, and case reports that are accessible to a wide audience given its open access policy. Located in London, England, Prostate Cancer has made significant strides in its category quartiles, achieving Q4 in Cancer Research and Q3 in both Oncology and Urology as of 2023, reflecting its growing relevance and readership. With Scopus rankings indicating its position within the broader medical fields, the journal is a valuable resource for researchers, professionals, and students alike, contributing to the collective effort to improve outcomes in prostate cancer research and treatment.
Canadian Journal of Urology
Elevating the standards of urological medicine in Canada.Canadian Journal of Urology, published by CANADIAN J UROLOGY, is a prominent peer-reviewed journal dedicated to advancing the field of urology and its allied disciplines. Established in 2000, this journal has consistently aimed to provide a platform for comprehensive research, clinical studies, and innovative practices in urology and general medicine, ensuring that professionals remain at the forefront of medical advancements. With a reputation reflected in its 2023 Scopus ranking of Q3 in both Urology and Medicine (miscellaneous), the journal serves as an essential resource for researchers and practitioners seeking to enhance their knowledge and application of urological sciences. Although it is not an Open Access journal, its impactful findings contribute significantly to the medical community in Canada and beyond, promoting evidence-based practices and contributing to better patient outcomes. As the journal converges into 2024, it continues to welcome high-quality submissions that explore critical challenges and advancements in urology.
BMC Urology
Pioneering Research in Urology and Reproductive MedicineBMC Urology is a premier open-access journal dedicated to advancing research in the field of urology, reproductive medicine, and miscellaneous aspects of medicine. Published by BMC since 2001 and based in the United Kingdom, this journal provides a platform for researchers, clinicians, and students to disseminate their findings and explore the latest innovations and advancements within these vital fields. With a notable impact factor and categorization in the Q2 quartile for various categories of medicine, BMC Urology stands as a reputable source, ranking 51st out of 120 in Urology and 44th out of 90 in Reproductive Medicine according to Scopus metrics. The journal fosters knowledge sharing through its open-access model, ensuring that research is accessible to all. As it converges from 2001 to 2024, BMC Urology continues to play a crucial role in shaping the landscape of urological research and providing invaluable insights into clinical practices.
WORLD JOURNAL OF UROLOGY
Empowering the Future of Urology through ResearchWORLD JOURNAL OF UROLOGY, published by Springer, stands as a premier journal in the field of urology, holding a commendable Q1 ranking in the 2023 category quartiles. With an ISSN of 0724-4983 and an E-ISSN of 1433-8726, this journal has been a vital resource since its inception in 1983, and continues to influence research up to 2024. Its ranking of 13th out of 120 in the Scopus Medicine Urology category, placing it in the 89th percentile, reflects its significant impact within the academic community. The journal aims to publish cutting-edge research, reviews, and clinical studies that advance knowledge in urological science and practice. Although it features no open access options, its rigorous peer-review process ensures that only the highest quality studies are disseminated, catering to a wide audience of researchers, medical professionals, and students eager to stay at the forefront of urological advancements.